‘It just doesn’t stop’: Perspectives of women who use drugs on increased overdoses during the COVID-19 pandemic
Patterns of socioeconomic marginalization and non-fatal overdose among people who use drugs: A gender-stratified repeated measures latent class analysis
Mitra S, Richardson L, Cui Z, Gilbert M, Milloy MJ, Hayashi K, Kerr T., Soc Sci Med. 2025
Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan-Canadian, randomized control trial
Crepeault H, Ti L, Bach P, Wood E, Jutras-Aswad D, Le Foll B, Lim R, Socias ME., Am J Addict. 2025
Qualitative findings from North America’s first drug compassion club
Bowles J, Nyx E, Kalicum J, Kerr T., PLoS One. 2024
“They talk about it like it’s an overdose crisis when in fact it’s basically genocide”: The experiences of Indigenous peoples who use illicit drugs in Vancouver’s Downtown Eastside neighbourhood
Lavalley J, Steinhauer L, Bundy DB, Kerr T, McNeil R., Int J Drug Policy, 2024.
Initiation and/or re-initiation of drug use among people who use drugs in Vancouver, Canada from 2021 to 2022: a prospective cohort study
Sergeant A, Bach P, Lei J, DeBeck K, Milloy MJ, Hayashi K., Subst Abuse Treat Prev Policy. 2024
The impact of an unsanctioned compassion club on non-fatal overdose
Kalicum J, Nyx E, Kennedy MC, Kerr T., Int J Drug Policy. 2024
Local Impact From International Crises: Unregulated Drug Toxicity During the COVID-19 Pandemic in British Columbia, Canada
Tobias S, Buxton JA, Ti L., Am J Public Health. 2024
Using drugs alone in single room occupancy housing: Understanding environmental drivers of overdose risk
Fleming T, Boyd J, Gagnon M, Kerr T, McNeil R., Int J Drug Policy. 2024
The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysis
Mitra S, Bouck Z, Larney S, Zolopa C, Høj S, Minoyan N, Upham K, Rammohan I, Mok WY, Hayashi K, Milloy MJ, DeBeck K, Scheim A, Werb D., Harm Reduct J. 2024
